| Literature DB >> 36132207 |
Zhongshun Yao1, Jiming Zhao1, Bin Zheng2, Zixiang Cong2, Yiming Zhang1, Jiaju Lv1,2, Zhihong Niu1,2, Fajuan Cheng3,4, Wei He1,2.
Abstract
Background: Laparoscopic partial nephrectomy (LPN) is the standard of care for localized small renal cancer. The most critical step in this form of surgery is to localize the renal artery. In the present study, we describe a novel technique that uses the left lumbar vein (LV) to access the left renal artery during LPN. Materials and methods: This was a retrospective review of 130 cases of transperitoneal laparoscopic partial nephrectomies (TLPNs) performed on patients with renal cancer in our center between January 2018 and December 2021. Either the LV or non-lumbar vein (N-LV) technique was used to locate and manage the left renal artery. We recorded relevant clinical data from all patients, including patient characteristics, tumor data, and perioperative outcomes (artery mobilization time, operative time, estimated blood loss, and complications). Comparative analysis was then carried out between the cases using LV or N-LV vein techniques.Entities:
Keywords: laparoscopy; lumbar vein; renal cell carcinoma; surgery; transperitoneal approach
Year: 2022 PMID: 36132207 PMCID: PMC9483022 DOI: 10.3389/fsurg.2022.858798
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1Perioperative computed tomography (CT) scans from two patients with renal cancer patients. (A,B) Renal contrast-enhanced CT demonstrating the lumbar vein (red arrow) and the left renal artery (blue arrow).
Figure 2Mobilization and identification of the left renal artery. (A) Tracing of the left gonadal vein (GV) leading to the left renal vein (RV) and the left lumbar vein (LV). (B) After securing and dividing the left LV, the left renal artery (RA) was brought into clear view.
Patient characteristics.
| Characteristic | LV ( | N-LV ( | |
|---|---|---|---|
| Age, years | 58.5 ± 10.2 | 56.0 ± 13.0 | 0.209 |
| Sex ( | |||
| Male | 55 (75.3%) | 39 (68.4%) | 0.382 |
| Female | 18 (24.7%) | 18 (31.6%) | |
| BMI, (kg/m2) | 26.0 ± 2.8 | 25.4 ± 2.9 | 0.275 |
| Tumor size (cm) | |||
| Median, range | 3.2 (2.5–3.7) | 3.5 (2.7–3.8) | 0.158 |
| Tumor location [ | |||
| Ventral surface of the middle part | 37 (50.7%) | 20 (35.0%) | 0.823 |
| Below the lower pole line | 46 (49.3%) | 37 (65.0%) | |
| RENAL risk group | |||
| Low complexity (score 4–6) | 58 (79.5%) | 42 (73.7%) | 0.44 |
| Moderate complexity (score 7–9) | 15 (20.5%) | 9 (26.3%) | |
| NYHA classification | |||
| I | 51 (70.0%) | 35 (61.4%) | 0.297 |
| II | 21 (28.6%) | 22 (38.6%) | |
| III | 1 (1.4%) | 0 | |
| ASA score | |||
| I | 1 (1.4%) | 0 | 0.560 |
| II | 58 (79.6%) | 46 (86.8%) | |
| III | 14 (19.0%) | 11 (13.2%) |
ASA, American Society of Anesthesiology; BMI, body mass index; LV, lumbar vein; N-LV, non-lumbar vein; NYHA, New York Heart Association.
Perioperative data.
| Characteristic | LV ( | N-LV ( | |
|---|---|---|---|
| Number of lumbar veins | |||
| One | 70 (95.9%) | 53 (92.9%) | 0.736 |
| Two | 3 (4.1%) | 4 (7.1%) | |
| Number of renal arteries | |||
| One | 58 (79.4%) | 47 (82.5%) | 0.706 |
| Two | 15 (20.6) | 9 (15.8%) | |
| Three | 0 | 1 (1.7%) | |
| Operative time | |||
| Median, range | 115 (105–140) | 125 (115–150) | 0.035* |
| Artery mobilization time | |||
| Median, range | 15 (14–17) | 19 (17–23) | <0.001* |
| EBL (ml) | |||
| Median, range | 50 (40–60) | 50 (40–80) | 0.037* |
| Day to surgical drain removed | |||
| Median, range | 3 (3–3) | 3 (3–4) | 0.083 |
| Postoperative hospital stay (days) | |||
| Median, range | 4 (4–5) | 4 (4–5) | 0.531 |
| Pathologic type [ | |||
| ccRCC | 64 (87.7%) | 51 (89.5%) | 0.873 |
| Others | 9 (12.3%) | 6 (10.5%) |
Artery mobilization time, the interval between entering the Gerota's fascia and success exposure of left renal artery; EBL, estimated blood loss; ccRCC, clear cell renal cell carcinoma.
*p < 0.05.